Literature DB >> 25398212

Genetic polymorphisms of the organic cation transporter 1 gene (SLC22A1) within the Cape Admixed population of South Africa.

Morne Du Plessis1, Brendon Pearce, Clifford Jacobs, Nisreen Hoosain, Mongi Benjeddou.   

Abstract

Human organic cation transporter 1 (hOCT1) is expressed primarily in hepatocytes and mediate the electrogenic transport of various endogenous and exogenous compounds, including clinically important drugs. Genetic polymorphisms in the gene coding for hOCT1, SLC22A1, are increasingly being recognized as a possible mechanism explaining the variable response of individual patients to clinical drugs which are substrates for this transporter. The aim of this study was to investigate the allele and genotype frequencies of single-nucleotide polymorphisms (SNPs) of SLC22A1 in the Cape Admixed population of South Africa. The genotypic and allelic distributions of nineteen nonsynonomous and one intronic SLC22A1 SNPs were determined in 100 healthy Cape Admixed participants, using a SNaPshot(®) multiplex assay. In addition, haplotype structure for SLC22A1 was inferred from the genotypic data. The minor allele frequencies for S14F, P341L, S189L, G220V, V519F, M440I, G465R and the rs622342 intronic variant were 1.0, 0.5, 1.0, 1.0, 1.5, 0.5, 0.5 and 18.0%, respectively. None of the participants carried the variant allele for R61C, C88R, P283L, R287G and G401S. In addition, no variant alleles were observed for A306T, A413V, M420V, I421F, C436F, V501E, and I542V in the population. Twelve haplotypes were inferred from the genotypic data. The frequencies for most common haplotypes CCTCGGCGCGCTAGAGCTGA, CCTCGGCGCGCTAGCGCTGA and CCTCGGCGCGCGAGCGCTGA were 80, 9.9, and 3.5%, respectively.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25398212     DOI: 10.1007/s11033-014-3813-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

1.  Natural variation in human membrane transporter genes reveals evolutionary and functional constraints.

Authors:  Maya K Leabman; Conrad C Huang; Joseph DeYoung; Elaine J Carlson; Travis R Taylor; Melanie de la Cruz; Susan J Johns; Doug Stryke; Michiko Kawamoto; Thomas J Urban; Deanna L Kroetz; Thomas E Ferrin; Andrew G Clark; Neil Risch; Ira Herskowitz; Kathleen M Giacomini
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

2.  Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions.

Authors:  Takeshi Sakata; Naohiko Anzai; Ho Jung Shin; Rie Noshiro; Taku Hirata; Hirokazu Yokoyama; Yoshikatsu Kanai; Hitoshi Endou
Journal:  Biochem Biophys Res Commun       Date:  2004-01-16       Impact factor: 3.575

3.  Allele frequencies of six non-CODIS miniSTR loci (D1S1627, D3S4529, D5S2500, D6S1017, D8S1115 and D9S2157) in three South African populations.

Authors:  Zainonesa Abrahams; Maria Eugenia D'Amato; Sean Davison; Mongi Benjeddou
Journal:  Forensic Sci Int Genet       Date:  2010-03-02       Impact factor: 4.882

4.  Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations.

Authors:  Sarah E Flanagan; Ann-Marie Patch; Sian Ellard
Journal:  Genet Test Mol Biomarkers       Date:  2010-08

5.  The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.

Authors:  M V Tzvetkov; S V Vormfelde; D Balen; I Meineke; T Schmidt; D Sehrt; I Sabolić; H Koepsell; J Brockmöller
Journal:  Clin Pharmacol Ther       Date:  2009-06-17       Impact factor: 6.875

Review 6.  The next steps for genomic medicine: challenges and opportunities for the developing world.

Authors:  Billie-Jo Hardy; Béatrice Séguin; Federico Goodsaid; Gerardo Jimenez-Sanchez; Peter A Singer; Abdallah S Daar
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

7.  Cloning and characterization of two human polyspecific organic cation transporters.

Authors:  V Gorboulev; J C Ulzheimer; A Akhoundova; I Ulzheimer-Teuber; U Karbach; S Quester; C Baumann; F Lang; A E Busch; H Koepsell
Journal:  DNA Cell Biol       Date:  1997-07       Impact factor: 3.311

8.  Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function.

Authors:  Maya K Leabman; Conrad C Huang; Michiko Kawamoto; Susan J Johns; Douglas Stryke; Thomas E Ferrin; Joseph DeYoung; Travis Taylor; Andrew G Clark; Ira Herskowitz; Kathleen M Giacomini
Journal:  Pharmacogenetics       Date:  2002-07

Review 9.  Recent advances of genetic ancestry testing in biomedical research and direct to consumer testing.

Authors:  M Via; E Ziv; E G Burchard
Journal:  Clin Genet       Date:  2009-09       Impact factor: 4.438

10.  GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research--an update.

Authors:  Rod Peakall; Peter E Smouse
Journal:  Bioinformatics       Date:  2012-07-20       Impact factor: 6.937

View more
  4 in total

Review 1.  Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions.

Authors:  C Arimany-Nardi; H Koepsell; M Pastor-Anglada
Journal:  Pharmacogenomics J       Date:  2015-11-03       Impact factor: 3.550

Review 2.  Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: A systematic review.

Authors:  Edith Pascale Mofo Mato; Magellan Guewo-Fokeng; M Faadiel Essop; Peter Mark Oroma Owira
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

Review 3.  Genetic Diversity in Drug Transporters: Impact in African Populations.

Authors:  Iris Rajman; Laura Knapp; Imad Hanna
Journal:  Clin Transl Sci       Date:  2020-03-31       Impact factor: 4.689

4.  Analysis of OCT1, OCT2 and OCT3 gene polymorphisms among Type 2 diabetes mellitus subjects in Indian ethnicity, Malaysia.

Authors:  Sabah Ghasan Abood Al-Ashoor; Vasudevan Ramachandran; Liyana Najwa Inche Mat; Nur Afiqah Mohamad; Mohd Hazmi Mohamed; Wan Aliaa Wan Sulaiman
Journal:  Saudi J Biol Sci       Date:  2021-09-14       Impact factor: 4.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.